CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Open-market sale President and CEO sold 11,694 shares at $6.29 ($73,555)
- 4 Open-market sale EVP & Chief Medical Officer sold 3,587 shares at $6.29 ($22,562)
- 4 Open-market sale EVP, Chief Development Officer sold 3,548 shares at $6.29 ($22,317)
- 4 Open-market sale Chief Accounting Officer sold 571 shares at $6.29 ($3,592)
- 4 Open-market sale SVP, General Counsel&Secretary sold 2,793 shares at $6.29 ($17,568)
- 4 Grant or award EVP & Chief Commercial Officer acquired 9,999 shares (grant or award)
- 4 Grant or award EVP & Chief Medical Officer acquired 9,999 shares (grant or award)
- 4 Grant or award EVP, Chief Development Officer acquired 9,583 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 933 shares (grant or award)
- 4 Grant or award President and CEO acquired 20,000 shares (grant or award)
- 4 Grant or award SVP, General Counsel&Secretary acquired 5,583 shares (grant or award)
- 4 Open-market sale EVP, Chief Development Officer sold 5,914 shares at $0.63 ($3,726)
- 4 Open-market sale President and CEO sold 4,099 shares at $0.65 ($2,664)
- 4 Grant or award EVP, CFO & Treasurer acquired 160,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 4,055 shares at $0.78 ($3,175)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 3,620 shares at $0.81 ($2,932)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 3,675 shares at $0.91 ($3,346)
- 4 Open-market sale President and CEO sold 3,607 shares at $0.88 ($3,172)
Page 4 of 31 · 601 filings